We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$22.7B
This Fund
S&P 500
This Quarter
Est. Return
+4.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
+$351M
(+3.3%)
Cap. Flow
-$94.6M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
2,523
New
200
Increased
627
Reduced
680
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$22.5M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$19.3M |
| 3 |
Cummins
CMI
|
+$18.1M |
| 4 |
Synaptics
SYNA
|
+$17.8M |
| 5 |
Radian Group
RDN
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$33.3M |
| 2 |
PL
PROTECTIVE LIFE CORP
PL
|
+$27.2M |
| 3 |
3M
MMM
|
+$19.1M |
| 4 |
AGN
Allergan Inc
AGN
|
+$15.5M |
| 5 |
MEAS
MEASUREMENT SPECIALTIES INC
MEAS
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.78% |
| 2 | Healthcare | 13.32% |
| 3 | Industrials | 13.19% |
| 4 | Miscellaneous | 12.05% |
| 5 | Financials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Honeywell
HON
$66.4B
| $69.6M | 0.63% |
833,866
+119,849
| +17% | +$10M |
|
27
JPMorgan Chase
JPM
$953B
| $69.5M | 0.63% |
1,207,015
+9,902
| +0.8% | +$557K |
|
28
Merck
MRK
$371B
| $69.3M | 0.62% |
1,255,552
+10,016
| +0.8% | +$546K |
|
29
Vanguard FTSE Developed Markets ETF
VEA
$241B
| $69.1M | 0.62% |
1,622,491
-1,256
| -0.1% | -$52.9K |
|
30
Abbott
ABT
$187B
| $67.2M | 0.6% |
1,644,160
+109,161
| +7% | +$4.29M |
|
31
Pfizer
PFE
$162B
| $65.5M | 0.59% |
2,326,487
-2,484
| -0.1% | -$70.8K |
|
32
American Express
AXP
$220B
| $63.8M | 0.57% |
672,573
-35,561
| -5% | -$3.21M |
|
33
Accenture
ACN
$114B
| $60.5M | 0.54% |
748,554
-61,928
| -8% | -$4.97M |
|
34
ConocoPhillips
COP
$161B
| $60.4M | 0.54% |
704,561
+29,395
| +4% | +$2.29M |
|
35
Colgate-Palmolive
CL
$70.8B
| $59.2M | 0.53% |
868,792
-23,053
| -3% | -$1.54M |
|
36
US Bancorp
USB
$98.7B
| $56.7M | 0.51% |
1,308,618
+11,528
| +0.9% | +$481K |
|
37
AbbVie
ABBV
$453B
| $56.7M | 0.51% |
1,003,928
-10,134
| -1% | -$532K |
|
38
Emerson Electric
EMR
$85.2B
| $56.2M | 0.5% |
846,246
-145,879
| -15% | -$9.81M |
|
39
Vanguard Dividend Appreciation ETF
VIG
$113B
| $55.9M | 0.5% |
717,078
+5,219
| +0.7% | +$399K |
|
40
Baxter International
BAX
$13.4B
| $53M | 0.48% |
1,350,132
+13,691
| +1% | +$548K |
|
41
AT&T
T
$176B
| $52.8M | 0.47% |
1,975,930
-184,495
| -9% | -$4.94M |
|
|
AGN
42
DELISTED
Allergan Inc
AGN
| $52.7M | 0.47% |
311,569
-99,806
| -24% | -$15.5M |
|
43
Franklin Templeton
BEN
$17.6B
| $52.6M | 0.47% |
910,265
-76,712
| -8% | -$4.2M |
|
44
Yum! Brands
YUM
$41.1B
| $46M | 0.41% |
787,629
-21,745
| -3% | -$1.21M |
|
45
Alphabet (Google) Class C
GOOG
$4.1T
| $44.8M | 0.4% |
1,549,362
+71,443
| +5% | +$1.94M |
|
46
Coca-Cola
KO
$379B
| $44.6M | 0.4% |
1,053,062
+1,877
| +0.2% | +$76.2K |
|
47
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.24B
| $44.1M | 0.4% |
944,585
+246,222
| +35% | +$11.2M |
|
48
NextEra Energy
NEE
$174B
| $43.5M | 0.39% |
1,699,248
-26,408
| -2% | -$642K |
|
49
Amgen
AMGN
$236B
| $43.1M | 0.39% |
364,295
+74,956
| +26% | +$8.68M |
|
50
Corning
GLW
$133B
| $43M | 0.39% |
1,958,252
-11,048
| -0.6% | -$234K |
|
Similar funds
EIM
SOMRS
CB
BBHC
CIG
LF
CI
Glenmede Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Glenmede Trust held 2,523 positions worth $11.1B, up 3.3% from $10.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust's Q2 2014 filing shows 200 new, 627 increased, 680 reduced and 198 closed positions. Its largest new stake was ARRIS International plc Ordinary Shares: 651,629 shares worth $21.2M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $33.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Glenmede Trust's largest Q2 2014 buy was ARRIS International plc Ordinary Shares: 651,629 shares worth $21.2M.
- Glenmede Trust added most to Boeing in Q2 2014, an estimated $22.5M increase.
- Glenmede Trust's biggest Q2 2014 reduction was PROTECTIVE LIFE CORP, cutting an estimated $27.2M.
- Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q2 2014, selling an estimated $33.3M.
- Glenmede Trust's ten largest holdings make up 14% of its $11.1B portfolio in Q2 2014.
- Glenmede Trust opened 200 new positions and closed 198 in Q2 2014.
- Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $11.1B.
Based on Glenmede Trust's 13F filing for Q2 2014, filed 13 Aug 2014.